Thomas Jung
Scientific Advisory Board
Topas Therapeutics
Germany
Biography
Thomas Jung is a physician-scientist experienced in Translational Sciences, Preclinical and Clinical Development of small molecules as well as biologics. His current role is Chief Development Officer at Auris Medical, Basel, Switzerland after having been Chief Medical Officer for Delenex Therapeutics, Zürich, Switzerland. Before that, Thomas was a member of Novartis’ R&D Group for a total of 13 years. His most recent role there was Head of Translational Medicine EU at Novartis, Basel, Switzerland. Thomas acts as a member of the Supervisory Board for AIMM Therapeutics, Amsterdam, The Netherlands. He is a board certified Dermatologist holding an Associate Professor position for Dermatology at the University of Göttingen, Germany.
Research Interest
Translational Sciences, Preclinical and Clinical Development of small molecules as well as biologics
